Table 2 General characteristics of the included studies.
First author | Year | Country | Detecting methods | Hemorrhagic | Controls | Ischemic | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of male patients | tHcy, μmol/L Mean ± SD | Age, Years | No. of male patients | tHcy, μmol/L Mean±SD | Age, Years | No. of male patients | tHcy, μmol/L Mean±SD | Age, Years | ||||
Bokhari FA | 2012 | Pakistan | ELISA | 4/9 | 23.73 ± 13.61 | NR | NR/33 | 20.73 ± 8.59 | NR | 10/22 | 20.45 ± 9.47 | NR |
Hiroyasu I | 2004 | Japan | HPLC | 17/38 | 10.4 ± 2.86 | 64.7 | 51/114 | 9.2 ± 3.1 | 64.4 | 60/98 | 9.8 ± 3.99 | 65.9 |
Fang X(+/−) | 2005 | Mongolia | HPLC | NR/12 | 15.6 ± 4.6 | NR | NR/6 | 12.9 ± 5.3 | NR | NR/18 | 18.4 ± 8.9 | NR |
Fang X(+/+) | 2005 | Mongolia | HPLC | NR/5 | 20 ± 6.4 | NR | NR/2 | 15.7 ± 6.3 | NR | NR/11 | 21.3 ± 1.8 | NR |
Li ZH | 2003 | China | HPLC | 318/503 | 14.6 ± 1.3 | 58.2 ± 9.6 | 1052/1832 | 12.8 ± 3.47 | 59.6 ± 8.8 | 513/807 | 14.7 ± 8.6 | 61.3 ± 9.7 |
Araki A | 1989 | Japan | HPLC | 13/20 | 9.6 ± 3.9 | 65.4 ± 9.7 | 30/45 | 7.3 ± 2.9 | 62.9 ± 10.8 | 30/45 | 13.1 ± 5.6 | 63.3 ± 10.9 |
Perini F | 2005 | Italy | HPLC | 39/70 | 18.18 ± 14.08 | 69.5 ± 13.8 | 201/421 | 11.97 ± 6.61 | 56.6 ± 14.8 | 399/775 | 18.94 ± 13.65 | 71.6 ± 12.1 |
Fang X(−/−) | 2005 | Mongolia | HPLC | NR/3 | 20.5 ± 8.6 | NR | NR/16 | 15.4 ± 4.2 | NR | NR/13 | 18.9 ± 8.0 | NR |
Peng H | 2000 | China | HPLC | NR/7 | 18.77 ± 5.58 | NR | 26/31 | 11.46 ± 5.96 | 51.8 | NR/32 | 18.72 ± 10.55 | NR |
